Experimental drug offered to patient with rare blood vessel disease
NCT ID NCT04914247
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 28 times
Summary
This program provides selexipag (Uptravi) to a single patient with Buerger's disease who has a wound that won't heal. The goal is to see if the drug can help control the disease and heal the wound. This is not a cure, but a way to manage the condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-HEALING WOUND are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.